SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

LLANOS-TEJADA, Félix  and  DEL CASTILLO, Hernán. Asociación entre tuberculosis infantil grave e inmunización previa con BCG en un hospital de referencia nacional, Perú 1990-2000. Rev Peru Med Exp Salud Publica [online]. 2012, vol.29, n.1, pp. 87-91. ISSN 1726-4634.  http://dx.doi.org/10.1590/S1726-46342012000100013.

    1. World Health Organization. guidance for national tuberculosis programmes on the management of tuberculosis in children. Section 6: BCG vaccination in children. Geneva: WHO; 2006. [ Links ]

    2. Y eager H. New drugs and vaccines. Dis Mon. 2007;53(1):59-63. [ Links ]

    3. Teo SS, Shingadia DV. Does BCG have a role in tuberculosis control and prevention in the United Kingdom? Arch Dis Child. 2006;91(6):529-31. [ Links ]

    4. Zhang LX, Tu DH, He GX, Ma ZQ, Nagelkerke NJ, Borgdorff MW, et al. Risk of tuberculosis infection and tuberculous meningitis after discontinuation of Bacillus Calmette Guerin in Beijing. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1314-7. [ Links ]

    5. Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, et al. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study. JAMA. 2004;291(17):2086-91 [ Links ]

    6. Boyd AE. BCG provides protection for a lifetime. Thorax. 2004;59:724. [ Links ]

    7. Brewer TF. Preventing tuberculosis with bacillus Calmette- Gurin vaccine: a meta-analysis of the literature. Clin Infect Dis. 2000;31 Suppl 3:S64-7. [ Links ]

    8. Sterne JA, Rodrigues LC, Guedes IN. Does the efficacy of BCG decline with time since vaccination? Int J Tuberc Lung Dis. 1998;2(3):200-7. [ Links ]

    9. Doherty TM, Andersen P. Vaccines for tuberculosis: novel concepts and recent progress. Clin Microbiol Rev. 2005;18(4):687-702. [ Links ]

    10. Martn C. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG? Eur Respir J. 2005;26(1):162-7. [ Links ]

    11. Vilaplana C, Gil O, Cceres N, Pinto S, Daz J, Cardona P. Prophylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosis. PLoS One. 2011;6(5):e20404. [ Links ]

    12. Abubakar I, Matthews T, Harmer D, Okereke E, Crawford K, Hall T, et al. Assessing the effect of foreign travel and protection by BCG vaccination on the spread of tuberculosis in a low incidence country, United Kingdom, October 2008 to December 2009. Euro Survell. 2011;16(12):19826. [ Links ]

    13. Guthmann JP, Antoine D, Fonteneau L, Che D, Lvy- Bruhl D. Assessing BCG vaccination coverage and incidence of paediatric tuberculosis following two major changes in BCG vaccination policy in France. Euro Survell. 2011;16(12):19824. [ Links ]

    14. Arbelez MP, Nelson KE, Muoz A. BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection. Int J Epidemiol. 2000;29(6):1085-91. [ Links ]

    15. Minassian AM, Ronan EO, Poyntz H, Hill AV, McShane H. Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy. PLoS One. 2011;6(5):e19840. [ Links ]